株探米国株
エドガーで原本を確認する
0001443669FALSE00014436692026-07-312026-07-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 31, 2026
Proto Labs, Inc.
(Exact name of registrant as specified in its charter)
Minnesota 001-35435 41-1939628
(State or other jurisdiction
of incorporation)		 (Commission File Number) (IRS Employer
Identification Number)
5540 Pioneer Creek Drive
Maple Plain, Minnesota
 55359
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(763) 479-3680
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02. Results of Operations and Financial Condition.
On July 31, 2026, Proto Labs, Inc. issued a press release announcing its second quarter 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
99.1
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:
July 31, 2026
 By: /s/ Daniel Schumacher
Daniel Schumacher
Chief Financial Officer

EX-99.1 2 prlb-2026731xexx991.htm EX-99.1 Document

Exhibit 99.1
logo.jpg
Protolabs Reports Financial Results for the Second Quarter of 2026
Record Quarterly Revenue of $149.3 Million, a 10.6% Increase Year-Over-Year
GAAP Earnings Per Share of $0.37, Non-GAAP Earnings Per Share of $0.60
Raising Full Year 2026 Revenue Growth Guidance from 6% - 8% to 8% - 10%
MINNEAPOLIS – July 31, 2026 – Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the second quarter ended June 30, 2026.

Second Quarter 2026 Financial Highlights:
•Revenue was a record $149.3 million, a 10.6% increase over the second quarter of 2025.
◦Total revenue per customer contact increased 16.7% year-over-year.
◦CNC machining revenue grew 13.6% year-over-year.
◦Injection molding revenue grew 13.1% year-over-year.
•GAAP gross margin was 46.4%, up from 44.3% in the second quarter of 2025. Non-GAAP gross margin was 46.8%, up 200 bps from 44.8% in the second quarter of 2025.
•GAAP operating margin was 7.6%, up from 3.7% in the second quarter of 2025. Non-GAAP operating margin was 12.0%, up 340 bps from 8.6% in the second quarter of 2025.
•GAAP net income was $0.37 per diluted share, compared to $0.18 per diluted share in the second quarter of 2025. Non-GAAP net income was $0.60 per diluted share, compared to $0.41 per diluted share in the second quarter of 2025.

Note: See “Non-GAAP Financial Measures” below.

"We delivered another strong quarter with record revenue, double-digit revenue growth, and both gross and operating margin expansion. More importantly, we are seeing increasing evidence that our strategy is gaining traction across the business, with larger strategic customers expanding their relationships with Protolabs," said President and Chief Executive Officer Suresh Krishna. "Through the first half of 2026, we have demonstrated that Protolabs can deliver strong financial performance while simultaneously transforming the business for the future. We are encouraged by the momentum we are seeing across customers, services, and regions."

Additional Second Quarter 2026 Financial Highlights:
•Adjusted EBITDA was $25.1 million, or 16.8% of revenue, compared to $19.7 million, or 14.6% of revenue, in the second quarter of 2025. See “Non-GAAP Financial Measures” below.
•Cash generated from operations was $15.4 million.
•Cash and investments balance was $162.9 million as of June 30, 2026.

"Record revenue and meaningful margin expansion in the second quarter highlight the strength and scalability of our business model," said Chief Financial Officer Dan Schumacher. "We continue to generate strong cash flow while investing in strategic growth initiatives, and we remain focused on balancing profitable growth with disciplined execution to drive value for customers and shareholders."

Financial Guidance and Outlook:

•For full year 2026, Protolabs is raising its guidance and now expects to generate revenue growth between 8% and 10%.
•For the third quarter of 2026, the Company expects revenue between $145.0 million and $153.0 million.


•For the third quarter of 2026, the Company expects GAAP diluted net income per share between $0.34 and $0.42, and non-GAAP diluted net income per share between $0.56 and $0.64. See "Non-GAAP Financial Measures" below.

Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth by region and by product line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”). Management believes these metrics, when viewed in conjunction with the comparable GAAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense, amortization expense and trade refunds and charges, net, in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income and non-GAAP net income per share, in each case, adjusted for stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP net income per share, non-GAAP gross margin, non-GAAP operating margin, non-GAAP revenue growth by region and by product line, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends, provide useful measures for period-to-period comparisons of the Company’s business, and in determining executive and senior management incentive compensation. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our condensed consolidated financial statements and are subject to inherent limitations. Investors should review the reconciliations of non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.
Conference Call
The Company has scheduled a conference call to discuss its second quarter 2026 financial results and third quarter 2026 outlook today, July 31, 2026, at 8:30 a.m. EDT. To access the call in the U.S., please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/9bgsjeh5/. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.


About Protolabs
Protolabs is the world’s fastest manufacturing service enabling companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey. Get started now at protolabs.com.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

Source: Proto Labs, Inc.

Investor Relations Contacts
Protolabs
Ryan Johnsrud, 612-225-4873
Sr. Manager – Investor Relations and Corporate Development
ryan.johnsrud@protolabs.com

Gateway Group, Inc.
949-574-3860
PRLB@gateway-grp.com
Media Contact
Protolabs
Brent Renneke, 763-479-7704
Corporate Communications Manager
brent.renneke@protolabs.com


Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
June 30,
2026		 December 31,
2025
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 127,918  $ 110,826 
Short-term marketable securities 14,858  17,297 
Accounts receivable, net 95,074  78,962 
Inventory 15,413  14,401 
Prepaid expenses and other current assets 11,590  9,590 
Income taxes receivable 1,390  2,465 
Total current assets 266,243  233,541 
Property and equipment, net 208,329  215,261 
Goodwill 273,991  273,991 
Other intangible assets, net 16,606  18,612 
Long-term marketable securities 20,120  14,308 
Operating lease assets 1,263  2,836 
Finance lease assets 290  424 
Other long-term assets 4,456  4,442 
Total assets $ 791,298  $ 763,415 
Liabilities and shareholders' equity
Current liabilities
Accounts payable $ 21,542  $ 15,104 
Accrued compensation 18,830  23,674 
Accrued liabilities and other 31,776  26,783 
Current operating lease liabilities 929  1,155 
Current finance lease liabilities 127  286 
Total current liabilities 73,204  67,002 
Long-term operating lease liabilities 1,185  1,606 
Long-term deferred tax liabilities 20,625  16,598 
Other long-term liabilities 4,551  4,277 
Shareholders' equity 691,733  673,932 
Total liabilities and shareholders' equity $ 791,298  $ 763,415 


Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Revenue
Injection Molding $ 53,625  $ 47,415  $ 104,693  $ 96,138 
CNC Machining 70,360  61,945  133,605  114,788 
3D Printing 20,667  21,215  41,132  41,409 
Sheet Metal 4,462  4,303  8,813  8,514 
Other Revenue 227  185  434  419 
Total revenue 149,341  135,063  288,677  261,268 
Cost of revenue 79,999  75,289  155,743  145,796 
Gross profit 69,342  59,774  132,934  115,472 
Operating expenses
Marketing and sales 25,682  24,731  50,462  48,480 
Research and development 10,791  11,173  21,331  21,782 
General and administrative 19,650  18,752  36,662  35,600 
Restructuring and transformation costs 924  —  2,345  — 
Costs related to exit and disposal activities 937  149  937  110 
Total operating expenses 57,984  54,805  111,737  105,972 
Income from operations 11,358  4,969  21,197  9,500 
Other income, net 1,245  1,705  2,723  3,159 
Income before income taxes 12,603  6,674  23,920  12,659 
Provision for income taxes 3,451  2,247  6,657  4,633 
Net income $ 9,152  $ 4,427  $ 17,263  $ 8,026 
Net income per share:
Basic $ 0.38  $ 0.19  $ 0.72  $ 0.33 
Diluted $ 0.37  $ 0.18  $ 0.71  $ 0.33 
Shares used to compute net income per share:
Basic 23,969,254 23,900,390 23,902,802 24,018,119
Diluted 24,415,788 24,101,592 24,358,568 24,291,246


Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Six Months Ended
June 30,
2026 2025
Operating activities
Net income $ 17,263  $ 8,026 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 16,161  17,264 
Stock-based compensation expense 7,307  8,251 
Deferred taxes 4,054  (3,985)
Interest on finance lease obligations 5  11 
Loss on impairment of equipment 186  — 
Impairments related to exit and closure of facilities 937  448 
Gain on disposal of property and equipment (120) — 
Other (152) (82)
Changes in operating assets and liabilities (12,663) (970)
Net cash provided by operating activities 32,978  28,963 
Investing activities
Purchases of property, equipment and other capital assets (9,743) (2,730)
Proceeds from sales of property, equipment and other capital assets 1,279  — 
Purchases of marketable securities (16,007) (11,052)
Proceeds from maturities of marketable securities 12,500  10,230 
Net cash used in investing activities (11,971) (3,552)
Financing activities
Proceeds from issuance of common stock from equity plans 7,265  2,081 
Purchases of shares withheld for tax obligations (5,951) (3,117)
Repurchases of common stock (5,036) (23,980)
Principal repayments of finance lease obligations (160) (153)
Net cash used in financing activities (3,882) (25,169)
Effect of exchange rate changes on cash and cash equivalents (33) 1,069 
Net increase in cash and cash equivalents 17,092  1,311 
Cash and cash equivalents, beginning of period 110,826  89,071 
Cash and cash equivalents, end of period $ 127,918  $ 90,382 


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs
GAAP net income $ 9,152  $ 4,427  $ 17,263  $ 8,026 
Add back:
Stock-based compensation expense 4,088  4,259  7,307  8,251 
Amortization expense 905  927  1,818  1,835 
Unrealized loss (gain) on foreign currency 137  (179) 137  (314)
Trade refunds and charges, net (327) —  (327) — 
Restructuring and transformation costs 924  —  2,345  — 
Costs related to exit and disposal activities 937  149  937  110 
CEO transition costs —  1,362  —  1,362 
Total adjustments 1
6,664  6,518  12,217  11,244 
Income tax benefits on adjustments 2
(1,111) (958) (1,697) (1,200)
Non-GAAP net income $ 14,705  $ 9,987  $ 27,783  $ 18,070 
Non-GAAP net income per share:
Basic $ 0.61  $ 0.42  $ 1.16  $ 0.75 
Diluted $ 0.60  $ 0.41  $ 1.14  $ 0.74 
Shares used to compute non-GAAP net income per share:
Basic 23,969,254 23,900,390 23,902,802 24,018,119
Diluted 24,415,788 24,101,592 24,358,568 24,291,246
1Stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, trade refunds and charges, net, restructuring and transformation costs, costs related to exit and disposal activities and CEO transition costs were included in the following GAAP consolidated statement of operations categories:
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Cost of revenue $ 549  $ 767  $ 1,285  $ 1,569 
Marketing and sales 819  808  1,524  1,586 
Research and development 641  735  1,069  1,360 
General and administrative 2,657  4,238  4,920  6,933 
Restructuring and transformation costs 924  —  2,345  — 
Costs related to exit and disposal activities 937  149  937  110 
Total operating expenses 5,978  5,930  10,795  9,989 
Other income, net 137  (179) 137  (314)
Total adjustments $ 6,664  $ 6,518  $ 12,217  $ 11,244 
2For the three and six months ended June 30, 2026 and 2025, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the respective period.


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Revenue $ 149,341  $ 135,063  $ 288,677  $ 261,268 
Gross profit 69,342  59,774  132,934  115,472 
GAAP gross margin 46.4 % 44.3 % 46.0 % 44.2 %
Add back:
Stock-based compensation expense 534  424  928  884 
Amortization expense 342  343  684  685 
Trade refunds and charges, net (327) —  (327) — 
Total adjustments 549  767  1,285  1,569 
Non-GAAP gross profit $ 69,891  $ 60,541  $ 134,219  $ 117,041 
Non-GAAP gross margin 46.8 % 44.8 % 46.5 % 44.8 %


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Revenue $ 149,341  $ 135,063  $ 288,677  $ 261,268 
Income from operations 11,358  4,969  21,197  9,500 
GAAP operating margin 7.6 % 3.7 % 7.3 % 3.6 %
Add back:
Stock-based compensation expense 4,088  4,259  7,307  8,251 
Amortization expense 905  927  1,818  1,835 
Trade refunds and charges, net (327) —  (327) — 
Restructuring and transformation costs 924  —  2,345  — 
Costs related to exit and disposal activities 937  149  937  110 
CEO transition costs —  1,362  —  1,362 
Total adjustments 6,527  6,697  12,080  11,558 
Non-GAAP income from operations $ 17,885  $ 11,666  $ 33,277  $ 21,058 
Non-GAAP operating margin 12.0 % 8.6 % 11.5 % 8.1 %


Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Revenue $ 149,341  $ 135,063  $ 288,677  $ 261,268 
GAAP net income 9,152  4,427  17,263  8,026 
GAAP net income margin 6.1 % 3.3 % 6.0 % 3.1 %
Add back:
Amortization expense $ 905  $ 927  $ 1,818  $ 1,835 
Depreciation expense 7,183  7,643  14,343  15,429 
Interest income, net (1,331) (1,143) (2,584) (2,251)
Provision for income taxes 3,451  2,247  6,657  4,633 
EBITDA 19,360  14,101  37,497  27,672 
EBITDA Margin 13.0 % 10.4 % 13.0 % 10.6 %
Add back:
Stock-based compensation expense 4,088  4,259  7,307  8,251 
Unrealized loss (gain) on foreign currency 137  (179) 137  (314)
Trade refunds and charges, net (327) —  (327) — 
Restructuring and transformation costs 924  —  2,345  — 
Costs related to exit and disposal activities 937  149  937  110 
CEO transition costs —  1,362  —  1,362 
Total adjustments 5,759  5,591  10,399  9,409 
Adjusted EBITDA $ 25,119  $ 19,692  $ 47,896  $ 37,081 
Adjusted EBITDA Margin 16.8 % 14.6 % 16.6 % 14.2 %


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
June 30, 2026		 Three Months Ended
June 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 122,759  $ —  $ 122,759  $ 110,712  10.9 % 10.9 %
Europe 26,582  (447) 26,135  24,351  9.2 7.3
Total revenue $ 149,341  $ (447) $ 148,894  $ 135,063  10.6 % 10.2 %
Six Months Ended
June 30, 2026		 Six Months Ended
June 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 234,886  $ —  $ 234,886  $ 210,979  11.3 % 11.3 %
Europe 53,791  (2,604) 51,187  50,289  7.0 1.8
Total revenue $ 288,677  $ (2,604) $ 286,073  $ 261,268  10.5 % 9.5 %

1Revenue for the three and six months ended June 30, 2026 has been recalculated using 2025 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2025 to GAAP revenue for the three and six months ended June 30, 2026.
3This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2025 to non-GAAP revenue for the three and six months ended June 30, 2026 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2025) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Product Line
(In thousands)
(Unaudited)
Three Months Ended
June 30, 2026		 Three Months Ended
June 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 53,625  $ (89) $ 53,536  $ 47,415  13.1 % 12.9 %
CNC Machining 70,360  (318) 70,042  61,945  13.6  13.1 
3D Printing 20,667  (30) 20,637  21,215  (2.6) (2.7)
Sheet Metal 4,462  (8) 4,454  4,303  3.7  3.5 
Other Revenue 227  (2) 225  185  22.7  21.6 
Total revenue $ 149,341  $ (447) $ 148,894  $ 135,063  10.6 % 10.2 %
Six Months Ended
June 30, 2026		 Six Months Ended
June 30, 2025
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 104,693  $ (720) $ 103,973  $ 96,138  8.9 % 8.1 %
CNC Machining 133,605  (1,432) 132,173  114,788  16.4  15.1 
3D Printing 41,132  (398) 40,734  41,409  (0.7) (1.6)
Sheet Metal 8,813  (50) 8,763  8,514  3.5  2.9 
Other Revenue 434  (4) 430  419  3.6  2.6 
Total revenue $ 288,677  $ (2,604) $ 286,073  $ 261,268  10.5 % 9.5 %

1Revenue for the three and six months ended June 30, 2026 has been recalculated using 2025 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2025 to GAAP revenue for the three and six months ended June 30, 2026.
3This column presents the percentage change from GAAP revenue for the three and six months ended June 30, 2025 to non-GAAP revenue for the three and six months ended June 30, 2026 (as recalculated using the foreign currency exchange rates in effect during the three and six months ended June 30, 2025) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)
Three Months Ended
June 30,		 Six Months Ended
June 30,
2026 2025 2026 2025
Revenue $ 149,341  $ 135,063  $ 288,677  $ 261,268 
Customer contacts 20,630 21,775 31,069 33,136
Revenue per customer contact1
$ 7,239  $ 6,203  $ 9,291  $ 7,885 

1Revenue per customer contact is calculated using the revenue recognized during the respective period divided by the actual number of customer contacts served during the same period. Customer contacts are product developers, engineers, procurement and supply chain professionals and other individuals who place an order, and that order is shipped and invoiced during the period. The Company believes revenue per customer contact is useful to investors in evaluating the underlying business trends and ongoing operating performance of the Company.
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)

Q3 2026 Outlook
Low High
GAAP diluted net income per share $ 0.34  $ 0.42 
Add back:
Stock-based compensation expense 0.19  0.19 
Amortization expense 0.03  0.03 
Total adjustments 0.22  0.22 
Non-GAAP diluted net income per share $ 0.56  $ 0.64